NCT01568099View on ClinicalTrials.gov

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

AFFITOPE® PD01A

s.c. injection

OTHER

Control

Untreated control

Trial Locations (1)

1080

Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, 1080 Vienna, Vienna

All Listed Sponsors
lead

Affiris AG

INDUSTRY

NCT01568099 - Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease | Biotech Hunter | Biotech Hunter